Adrian M. Whelan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Adrian M. Whelan has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Elaine Ku
Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, USA
5 shared publications Charles E. McCulloch
University of California, San Francisco, Department of Epidemiology and Biostatistics
4 shared publicationsKirsten L. Johansen
Hennepin County Medical Center and University of Minnesota, Division of Nephrology, Department of Medicine
3 shared publicationsBarbara A. Grimes
Department of Epidemiology and Biostatistics, University of California, San Francisco, USA
2 shared publicationsBarbara Grimes
Department of Epidemiology and Biostatistics, University of California, San Francisco, California
2 shared publications- Charles E. McCulloch
Department of Epidemiology and Biostatistics University of California, San Francisco San Francisco California USA
2 shared publications
Latest Publications
- 23 August 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 26  (1) , 186-189
Probable reactivation from latency of multidrug-resistant cytomegalovirus in a lung transplant recipient: A case report
- 23 August 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 26  (1) , 186-189
Probable reactivation from latency of multidrug-resistant cytomegalovirus in a lung transplant recipient: A case report
- 6 December 2024
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 36  (6) , 1164-1172
Pediatric Nephrology Workforce and Access of Children with Kidney Failure to Transplantation in the United States
Key Points: Pediatric nephrologists play a critical role in evaluating children with kidney failure for transplant candidacy. Nephrology is one of the pediatric subspecialties with the greatest workforce shortage in the United States. Children residing in states with the highest density of pediatric nephrologists had better access to waitlisting and deceased donor transplantation. Background: Nephrology is one of the pediatric subspecialties with the largest workforce shortage in the United States. Waitlist registration is one of the first steps toward kidney transplantation and is facilitated by pediatric nephrologists. The objective of this study was to determine whether state-level density of pediatric nephrologists is associated with access to waitlisting (primary outcome) or kidney transplantation (secondary outcome) in children with kidney failure. Methods: Using Cox proportional hazards and logistic regression analyses, we studied children younger than 18 years who developed kidney failure between 2016 and 2020 according to the United States Renal Data System, the national kidney failure registry. The density of pediatric nephrologists (determined by the count of pediatric nephrologists per 100,000 children in each state) was estimated using workforce data from the American Board of Pediatrics and categorized into three groups: >1, 0.5–1, and 1 had 33% (hazard ratio [HR], 1.33; 95% confidence interval [CI], 1.07 to 1.66) and 22% (HR, 1.22; 95% CI, 1.02 to 1.45) better access to waitlisting compared with those residing in states with 1 compared with the reference group. Conclusions: Children residing in states with higher pediatric nephrologist density had better access to waitlist registration, especially preemptively, and deceased donor transplantation.
- 6 December 2024
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 36  (6) , 1164-1172
Pediatric Nephrology Workforce and Access of Children with Kidney Failure to Transplantation in the United States
Key Points: Pediatric nephrologists play a critical role in evaluating children with kidney failure for transplant candidacy. Nephrology is one of the pediatric subspecialties with the greatest workforce shortage in the United States. Children residing in states with the highest density of pediatric nephrologists had better access to waitlisting and deceased donor transplantation. Background: Nephrology is one of the pediatric subspecialties with the largest workforce shortage in the United States. Waitlist registration is one of the first steps toward kidney transplantation and is facilitated by pediatric nephrologists. The objective of this study was to determine whether state-level density of pediatric nephrologists is associated with access to waitlisting (primary outcome) or kidney transplantation (secondary outcome) in children with kidney failure. Methods: Using Cox proportional hazards and logistic regression analyses, we studied children younger than 18 years who developed kidney failure between 2016 and 2020 according to the United States Renal Data System, the national kidney failure registry. The density of pediatric nephrologists (determined by the count of pediatric nephrologists per 100,000 children in each state) was estimated using workforce data from the American Board of Pediatrics and categorized into three groups: >1, 0.5–1, and 1 had 33% (hazard ratio [HR], 1.33; 95% confidence interval [CI], 1.07 to 1.66) and 22% (HR, 1.22; 95% CI, 1.02 to 1.45) better access to waitlisting compared with those residing in states with 1 compared with the reference group. Conclusions: Children residing in states with higher pediatric nephrologist density had better access to waitlist registration, especially preemptively, and deceased donor transplantation.
- Open Access
- 28 September 2023
- Published by Springer Nature in Pediatric Nephrology
- Vol. 39  (4) , 1239-1244
Rurality of patient residence and access to transplantation among children with kidney failure in the United States
Background: Residence in rural areas is often a barrier to health care access. To date, differences in access to kidney transplantation among children who reside in rural and micropolitan areas of the US have not been explored. Methods: A retrospective cohort study of children < 18 years who developed kidney failure between 2000 and 2019 according to the United States Renal Data System (USRDS). We examined the association between rurality of patient residence and time to living and/or deceased donor kidney transplantation (primary outcomes) and waitlist registration (secondary outcome) using Fine–Gray models. Results: We included 18,530 children, of whom 14,175 (76.5%) received a kidney transplant (39.8% from a living and 60.2% from a deceased donor). Residence in micropolitan (subhazard ratio (SHR) 1.16; 95% CI 1.06–1.27) and rural (SHR 1.18; 95% CI 1.06–1.3) areas was associated with better access to living donor transplantation compared with residence in metropolitan areas. There was no statistically significant association between residence in micropolitan (SHR, 0.95; 95%CI 0.88–1.03) and rural (SHR, 0.94; 95%CI 0.86–1.03) areas compared with metropolitan areas in the access of children to deceased donor transplantation. There was also no difference in the time to waitlist registration comparing micropolitan (SHR 1.04; 95%CI 0.98–1.10) and rural (SHR 1.05; 95% CI 0.98–1.13) versus metropolitan areas. Conclusions: In children with kidney failure, residence in rural and micropolitan areas was associated with better access to living donor transplantation and similar access to deceased donor transplantation compared with residence in metropolitan areas. Graphical
- 28 September 2023
- Published by Springer Nature in Pediatric Nephrology
- Vol. 39  (4) , 1239-1244
Open AccessRurality of patient residence and access to transplantation among children with kidney failure in the United States
Background: Residence in rural areas is often a barrier to health care access. To date, differences in access to kidney transplantation among children who reside in rural and micropolitan areas of the US have not been explored. Methods: A retrospective cohort study of children < 18 years who developed kidney failure between 2000 and 2019 according to the United States Renal Data System (USRDS). We examined the association between rurality of patient residence and time to living and/or deceased donor kidney transplantation (primary outcomes) and waitlist registration (secondary outcome) using Fine–Gray models. Results: We included 18,530 children, of whom 14,175 (76.5%) received a kidney transplant (39.8% from a living and 60.2% from a deceased donor). Residence in micropolitan (subhazard ratio (SHR) 1.16; 95% CI 1.06–1.27) and rural (SHR 1.18; 95% CI 1.06–1.3) areas was associated with better access to living donor transplantation compared with residence in metropolitan areas. There was no statistically significant association between residence in micropolitan (SHR, 0.95; 95%CI 0.88–1.03) and rural (SHR, 0.94; 95%CI 0.86–1.03) areas compared with metropolitan areas in the access of children to deceased donor transplantation. There was also no difference in the time to waitlist registration comparing micropolitan (SHR 1.04; 95%CI 0.98–1.10) and rural (SHR 1.05; 95% CI 0.98–1.13) versus metropolitan areas. Conclusions: In children with kidney failure, residence in rural and micropolitan areas was associated with better access to living donor transplantation and similar access to deceased donor transplantation compared with residence in metropolitan areas. Graphical
- Open Access
- 24 March 2022
- Published by Elsevier in American Journal of Transplantation
- Vol. 22  (6) , 1624-1636
Kidney transplant candidacy evaluation and waitlisting practices in the United States and their association with access to transplantation
- 24 March 2022
- Published by Elsevier in American Journal of Transplantation
- Vol. 22  (6) , 1624-1636
Open AccessKidney transplant candidacy evaluation and waitlisting practices in the United States and their association with access to transplantation
- Open Access
- 16 March 2022
- Published by Springer Nature in Current Transplantation Reports
- Vol. 9  (2) , 127-142
Evaluation of Genetic Kidney Diseases in Living Donor Kidney Transplantation: Towards Precision Genomic Medicine in Donor Risk Assessment
Purpose of Review: To provide a comprehensive update on the role of genetic testing for the evaluation of kidney transplant recipient and living donor candidates.Recent Findings: The evaluation of candidates for living donor transplantation and their potential donors occurs within an ever-changing landscape impacted by new evidence and risk assessment techniques. Criteria that were once considered contraindications to living kidney donation are now viewed as standard of care, while new tools identify novel risk markers that were unrecognized in past decades. Recent work suggests that nearly 10% of a cohort of patients with chronic/end-stage kidney disease had an identifiable genetic etiology, many whose original cause of renal disease was either unknown or misdiagnosed. Some also had an incidentally found genetic variant, unrelated to their nephropathy, but medically actionable. These patterns illustrate the substantial potential for genetic testing to better guide the selection of living donors and recipients, but guidance on the proper application and interpretation of novel technologies is in its infancy. In this review, we examine the utility of genetic testing in various kidney conditions, and discuss risks and unresolved challenges. Suggested algorithms in the context of related and unrelated donation are offered.Summary: Genetic testing is a rapidly evolving strategy for the evaluation of candidates for living donor transplantation and their potential donors that has potential to improve risk assessment and optimize the safety of donation.
- 16 March 2022
- Published by Springer Nature in Current Transplantation Reports
- Vol. 9  (2) , 127-142
Open AccessEvaluation of Genetic Kidney Diseases in Living Donor Kidney Transplantation: Towards Precision Genomic Medicine in Donor Risk Assessment
Purpose of Review: To provide a comprehensive update on the role of genetic testing for the evaluation of kidney transplant recipient and living donor candidates.Recent Findings: The evaluation of candidates for living donor transplantation and their potential donors occurs within an ever-changing landscape impacted by new evidence and risk assessment techniques. Criteria that were once considered contraindications to living kidney donation are now viewed as standard of care, while new tools identify novel risk markers that were unrecognized in past decades. Recent work suggests that nearly 10% of a cohort of patients with chronic/end-stage kidney disease had an identifiable genetic etiology, many whose original cause of renal disease was either unknown or misdiagnosed. Some also had an incidentally found genetic variant, unrelated to their nephropathy, but medically actionable. These patterns illustrate the substantial potential for genetic testing to better guide the selection of living donors and recipients, but guidance on the proper application and interpretation of novel technologies is in its infancy. In this review, we examine the utility of genetic testing in various kidney conditions, and discuss risks and unresolved challenges. Suggested algorithms in the context of related and unrelated donation are offered.Summary: Genetic testing is a rapidly evolving strategy for the evaluation of candidates for living donor transplantation and their potential donors that has potential to improve risk assessment and optimize the safety of donation.
- 3 May 2021
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 32  (5) , 1151-1161
Association between Longer Travel Distance for Transplant Care and Access to Kidney Transplantation and Graft Survival in the United States
Significance Statement: Kidney transplantation rates and outcomes vary across transplant centers. Some patients may gain an advantage by traveling to a center with characteristics more favorable than those of the center nearest their residence. The authors examined patient and center characteristics associated with longer travel distance and the latter’s association with receipt of kidney transplantation and graft survival in the United States. Patients were more likely to travel farther if they were of non-Black race or if the nearest center had a lower volume of living donor surgeries. Longer travel distance associated with higher likelihood of living donor transplantation but lower likelihood of deceased donor transplantation, and it was weakly associated with higher graft failure risk. These findings provide insights into advantages (or lack thereof) of traveling beyond the nearest center for transplant care. Background: Transplant candidates may gain an advantage by traveling to receive care at a transplant center that may have more favorable characteristics than their local center. Factors associated with longer travel distance for transplant care and whether the excess travel distance (ETD) is associated with access to transplantation or with graft failure are unknown. Methods: This study of adults in the United States wait-listed for kidney transplantation in 1995–2015 used ETD, defined as distance a patient traveled beyond the nearest transplant center for initial waiting list registration. We used linear regression to examine patient and center characteristics associated with ETD and Fine–Gray models to examine the association between ETD (modeled as a spline) and time to deceased or living donor transplantation or graft failure. Results: Of 373,365 patients, 11% had an ETD≥50 miles. Traveling excess distance was more likely among patients who were of non-Black race or those whose nearest transplant center had lower annual living donor transplant volume. At an ETD of 50 miles, we observed a lower likelihood of deceased donor transplantation (subhazard ratio [SHR], 0.85; 95% confidence interval [95% CI], 0.84 to 0.87) but higher likelihood of living donor transplantation (SHR, 1.14; 95% CI, 1.12 to 1.16) compared with those who received care at their nearest center. ETD was weakly associated with higher risk of graft failure. Conclusions: Patients who travel excess distances for transplant care have better access to living donor but not deceased donor transplantation and slightly higher risk of graft failure. Traveling excess distances is not clearly associated with better outcomes, especially if living donors are unavailable.
- 3 May 2021
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 32  (5) , 1151-1161
Association between Longer Travel Distance for Transplant Care and Access to Kidney Transplantation and Graft Survival in the United States
Significance Statement: Kidney transplantation rates and outcomes vary across transplant centers. Some patients may gain an advantage by traveling to a center with characteristics more favorable than those of the center nearest their residence. The authors examined patient and center characteristics associated with longer travel distance and the latter’s association with receipt of kidney transplantation and graft survival in the United States. Patients were more likely to travel farther if they were of non-Black race or if the nearest center had a lower volume of living donor surgeries. Longer travel distance associated with higher likelihood of living donor transplantation but lower likelihood of deceased donor transplantation, and it was weakly associated with higher graft failure risk. These findings provide insights into advantages (or lack thereof) of traveling beyond the nearest center for transplant care. Background: Transplant candidates may gain an advantage by traveling to receive care at a transplant center that may have more favorable characteristics than their local center. Factors associated with longer travel distance for transplant care and whether the excess travel distance (ETD) is associated with access to transplantation or with graft failure are unknown. Methods: This study of adults in the United States wait-listed for kidney transplantation in 1995–2015 used ETD, defined as distance a patient traveled beyond the nearest transplant center for initial waiting list registration. We used linear regression to examine patient and center characteristics associated with ETD and Fine–Gray models to examine the association between ETD (modeled as a spline) and time to deceased or living donor transplantation or graft failure. Results: Of 373,365 patients, 11% had an ETD≥50 miles. Traveling excess distance was more likely among patients who were of non-Black race or those whose nearest transplant center had lower annual living donor transplant volume. At an ETD of 50 miles, we observed a lower likelihood of deceased donor transplantation (subhazard ratio [SHR], 0.85; 95% confidence interval [95% CI], 0.84 to 0.87) but higher likelihood of living donor transplantation (SHR, 1.14; 95% CI, 1.12 to 1.16) compared with those who received care at their nearest center. ETD was weakly associated with higher risk of graft failure. Conclusions: Patients who travel excess distances for transplant care have better access to living donor but not deceased donor transplantation and slightly higher risk of graft failure. Traveling excess distances is not clearly associated with better outcomes, especially if living donors are unavailable.
- Open Access
- 30 November 2020
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15  (11) , e0242784
Weighing the waitlist: Weight changes and access to kidney transplantation among obese candidates
High body mass index is a known barrier to access to kidney transplantation in patients with end-stage kidney disease. The extent to which weight and weight changes affect access to transplantation among obese candidates differentially by race/ethnicity has received little attention. We included 10 221 obese patients waitlisted for kidney transplantation prior to end-stage kidney disease onset between 1995–2015. We used multinomial logistic regression models to examine the association between race/ethnicity and annualized change in body mass index (defined as stable [-2 to 2 kg/m2/year], loss [>2 kg/m2/year] or gain [>2 kg/m2/year]). We then used Fine-Gray models to examine the association between weight changes and access to living or deceased donor transplantation by race/ethnicity, accounting for the competing risk of death. Overall, 29% of the cohort lost weight and 7% gained weight; 46% received a transplant. Non-Hispanic blacks had a 24% (95% CI 1.12–1.38) higher odds of weight loss and 22% lower odds of weight gain (95% CI 0.64–0.95) compared with non-Hispanic whites. Hispanics did not differ from whites in their odds of weight loss or weight gain. Overall, weight gain was associated with lower access to transplantation (HR 0.88 [95% CI 0.79–0.99]) compared with maintenance of stable weight, but weight loss was not associated with better access to transplantation (HR 0.96 [95% CI 0.90–1.02]), although this relation differed by baseline body mass index and for recipients of living versus deceased donor organs. For example, weight loss was associated with improved access to living donor transplantation (HR 1.24 [95% CI 1.07–1.44]) in whites but not in blacks or Hispanics. In a cohort of obese patients waitlisted before dialysis, blacks were more likely to lose weight and less likely to gain weight compared with whites. Weight loss was only associated with improved access to living donor transplantation among whites. Further studies are needed to understand the reasons for the observed associations.
- 30 November 2020
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15  (11) , e0242784
Open AccessWeighing the waitlist: Weight changes and access to kidney transplantation among obese candidates
High body mass index is a known barrier to access to kidney transplantation in patients with end-stage kidney disease. The extent to which weight and weight changes affect access to transplantation among obese candidates differentially by race/ethnicity has received little attention. We included 10 221 obese patients waitlisted for kidney transplantation prior to end-stage kidney disease onset between 1995–2015. We used multinomial logistic regression models to examine the association between race/ethnicity and annualized change in body mass index (defined as stable [-2 to 2 kg/m2/year], loss [>2 kg/m2/year] or gain [>2 kg/m2/year]). We then used Fine-Gray models to examine the association between weight changes and access to living or deceased donor transplantation by race/ethnicity, accounting for the competing risk of death. Overall, 29% of the cohort lost weight and 7% gained weight; 46% received a transplant. Non-Hispanic blacks had a 24% (95% CI 1.12–1.38) higher odds of weight loss and 22% lower odds of weight gain (95% CI 0.64–0.95) compared with non-Hispanic whites. Hispanics did not differ from whites in their odds of weight loss or weight gain. Overall, weight gain was associated with lower access to transplantation (HR 0.88 [95% CI 0.79–0.99]) compared with maintenance of stable weight, but weight loss was not associated with better access to transplantation (HR 0.96 [95% CI 0.90–1.02]), although this relation differed by baseline body mass index and for recipients of living versus deceased donor organs. For example, weight loss was associated with improved access to living donor transplantation (HR 1.24 [95% CI 1.07–1.44]) in whites but not in blacks or Hispanics. In a cohort of obese patients waitlisted before dialysis, blacks were more likely to lose weight and less likely to gain weight compared with whites. Weight loss was only associated with improved access to living donor transplantation among whites. Further studies are needed to understand the reasons for the observed associations.
- Open Access
- 17 September 2020
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 6  (10) , e602
Longer Distance From Dialysis Facility to Transplant Center Is Associated With Lower Access to Kidney Transplantation
Background.: Rates of kidney transplantation vary substantially across dialysis facilities in the United States. Whether distance between the dialysis facility and transplant center associates with variations in transplantation rates has not been examined. Methods.: We performed a retrospective study of adults treated with dialysis between 2005 and 2015, according to the US Renal Data System. We examined the association between distance from dialysis facility to transplant center and time to kidney transplantation (primary outcome) and waitlist registration (secondary outcome) using Fine-Gray models. We also performed sensitivity analyses using the distance from each patient’s dialysis facility to the nearest transplant center as the predictor so that patients who were never registered on the waitlist (and therefore would not have a transplant center) could be included. Results.: In total, 178 885 waitlisted patients were included for our primary analysis. As distance between dialysis facility and transplant center increased, lower hazard of transplantation (subhazard ratio [HR], 0.92; 95% confidence interval [CI], 0.91-0.94, if distance was 10 to <50 miles; sub-HR, 0.90; 95% CI, 0.88-0.92, if distance ≥50 miles compared with <10 miles) was noted. We also found a weak association between longer distance and hazard of waitlist registration (sub-HR, 0.96; 95% CI, 0.94-0.97, if distance was ≥50 miles versus <10 miles). Findings were similar in sensitivity analyses using distance between dialysis facility and the nearest transplant center (N = 1 149 721). Conclusions.: Patients receiving dialysis in facilities located further away from transplant centers have lower hazard of kidney transplantation. Developing strategies to address barriers to transplantation in patients receiving dialysis at facilities located far away from a transplant center may help improve disparities in transplantation rates.
- 17 September 2020
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 6  (10) , e602
Open AccessLonger Distance From Dialysis Facility to Transplant Center Is Associated With Lower Access to Kidney Transplantation
Background.: Rates of kidney transplantation vary substantially across dialysis facilities in the United States. Whether distance between the dialysis facility and transplant center associates with variations in transplantation rates has not been examined. Methods.: We performed a retrospective study of adults treated with dialysis between 2005 and 2015, according to the US Renal Data System. We examined the association between distance from dialysis facility to transplant center and time to kidney transplantation (primary outcome) and waitlist registration (secondary outcome) using Fine-Gray models. We also performed sensitivity analyses using the distance from each patient’s dialysis facility to the nearest transplant center as the predictor so that patients who were never registered on the waitlist (and therefore would not have a transplant center) could be included. Results.: In total, 178 885 waitlisted patients were included for our primary analysis. As distance between dialysis facility and transplant center increased, lower hazard of transplantation (subhazard ratio [HR], 0.92; 95% confidence interval [CI], 0.91-0.94, if distance was 10 to <50 miles; sub-HR, 0.90; 95% CI, 0.88-0.92, if distance ≥50 miles compared with <10 miles) was noted. We also found a weak association between longer distance and hazard of waitlist registration (sub-HR, 0.96; 95% CI, 0.94-0.97, if distance was ≥50 miles versus <10 miles). Findings were similar in sensitivity analyses using distance between dialysis facility and the nearest transplant center (N = 1 149 721). Conclusions.: Patients receiving dialysis in facilities located further away from transplant centers have lower hazard of kidney transplantation. Developing strategies to address barriers to transplantation in patients receiving dialysis at facilities located far away from a transplant center may help improve disparities in transplantation rates.
- Open Access
- 1 September 2019
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 74  (3) , 287-289
The AJKD Editorial Internship: Insights From the Inaugural Class of Editorial Interns
- 1 September 2019
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 74  (3) , 287-289
Open AccessThe AJKD Editorial Internship: Insights From the Inaugural Class of Editorial Interns
- 5 March 2019
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 34  (9) , 1437-1439
Use of ambulatory blood pressure monitoring in kidney transplant recipients
In this issue of NDT Mallamaci et al. [1], report on the results from a cohort study of longitudinal blood pressure (BP) measurements in kidney transplant recipients and compare routinely measured office BPs with 24-h ambulatory BPs (ABPs). The investigators found that white coat hypertension was present in 25% and masked hypertension in 12% of kidney transplant recipients. The authors found generally poor agreement between office BP and ABP readings, with misclassification of BP control status at 37% of visits, where a therapeutic change in BP management may have been indicated. The study focused on office BPs taken routinely in clinical practice rather than standardized research measurements per protocol. While...
- 5 March 2019
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 34  (9) , 1437-1439
Use of ambulatory blood pressure monitoring in kidney transplant recipients
In this issue of NDT Mallamaci et al. [1], report on the results from a cohort study of longitudinal blood pressure (BP) measurements in kidney transplant recipients and compare routinely measured office BPs with 24-h ambulatory BPs (ABPs). The investigators found that white coat hypertension was present in 25% and masked hypertension in 12% of kidney transplant recipients. The authors found generally poor agreement between office BP and ABP readings, with misclassification of BP control status at 37% of visits, where a therapeutic change in BP management may have been indicated. The study focused on office BPs taken routinely in clinical practice rather than standardized research measurements per protocol. While...